0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query mrrpb5 global acute repetitive seizures drugs market size status forecast 2019 2025.Your search for "" gave back 1533058 results.
An epileptic seizure is a brief episode of signs or symptoms due to abnormally excessive or synchronous neuronal activity in the brain. The global...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Ischemia Reperfusion Injury - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
Catalog:
Global Markets Direct
November 2019
Price: USD 2,000.00
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
January 2020
Price: USD 2,000.00
Ischemia Reperfusion Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets...
Catalog:
Global Markets Direct
March 2022
Price: USD 2,000.00
The global Seizure Treatments market size was valued at US$ million in 2023. With growing demand in downstream market, the Seizure Treatments is...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Organophosphate and Carbamate Poisoning - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Acute Renal Failure (ARF) (Acute Kidney Injury) (Genitourinary Disorders) - Drugs in Development, 2021 Summary Global Markets Direct's latest...
Catalog:
Global Markets Direct
March 2021
Price: USD 2,500.00
Encephalopathy - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
Catalog:
Global Markets Direct
December 2019
Price: USD 2,000.00
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
July 2018
Price: USD 2,000.00
Acute Renal Failure (ARF) (Acute Kidney Injury) - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
Catalog:
Global Markets Direct
July 2020
Price: USD 2,000.00
Acute Renal Failure (ARF) (Acute Kidney Injury) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary...
Catalog:
Global Markets Direct
March 2022
Price: USD 2,000.00
Swedish porphyria is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Acute Migraine Drugs market size was valued at USD 2165.3 million in 2023 and is forecast to a readjusted size of USD 3473.9 million by...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Acute Ischemic Stroke (CIS), also known as Cerebral Infarction (CI), is due to the occlusion of the Cerebral artery caused by the Infarction of brain...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
